Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

Aug 22, 2014

Regulatory, Supply Issues Haunt Ebola Drug Makers

Medical staff and supplies are urgently needed to fight the disease.

Regulatory, Supply Issues Haunt Ebola Drug Makers

National and international organizations, scientists, and companies are all on the search for new treatments and potential cures. [© luchschen_shutter - Fotolia.com]

  • As of August 16th, 2,240 individuals had contracted Ebola virus—a filovirus causing a hemorrhagic fever in humans and nonhuman primates so deadly that it ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.
    •  


Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »